US WorldMeds, LLC
Privately held: no public share price
Assets
(2 total)
2Total Assets
1Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
afamitresgene autoleucel(TECELRA) | Approved | MAGE-A4Cell therapy | Soft Tissue Sarcoma Synovial Sarcoma |
| Phase 2 | NY-ESO-1 / LAGE-1a (HLA-A*02)Cell therapy | Soft Tissue Sarcoma Myxoid/Round Cell Liposarcoma |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.